NCT01169792View on ClinicalTrials.gov

Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients

CompletedOBSERVATIONAL
Timeline

Start Date

Not specified

Conditions
Breast NeoplasmsSurvival AnalysisAntineoplastic AgentsTherapeutic Uses
Interventions
DRUG

tamoxifen

Trial Locations (2)

, 614-735

Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Jin-Gu

120-752

Department of Surgery, Yonsei University College of Medicine, Saedaemoon-gu

All Listed Sponsors
collaborator

Inje University

OTHER

lead

Yonsei University

OTHER

NCT01169792 - Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients | Biotech Hunter | Biotech Hunter